• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 14 of 100
Lars Fruergaard Jorgensen
Health
Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By BloombergAugust 7, 2024
An Ozempic (semaglutide) injection pen is seen on a kitchen table.
Health
How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By Arthur Allen and KFF Health NewsAugust 7, 2024
Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
Commentary
Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
By Michael SapienzaAugust 2, 2024
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Magazine
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
By Erika FryAugust 2, 2024
Only an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’
Conferences
Only an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’
By Christiaan HetznerJuly 31, 2024
Angela Fitch. cofounder and chief medical officer of knownwell.
Commentary
I’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad
By Angela FitchJuly 30, 2024
Thomas Schinecker, chief executive officer of Roche
Finance
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
David Rubenstein
Finance
A CEO abruptly resigned from a board after leaked emails reportedly showed inappropriate influence
By Marion Halftermeyer and BloombergJuly 26, 2024
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
Health
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By Marco Quiroz-GutierrezJuly 23, 2024
Thomas Schinecker, CEO of Roche Holding.
Retail
An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
By Naomi Kresge, Lisa Pham and BloombergJuly 23, 2024
A bathroom scale is surrounded by colorful pills.
Health
Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
By Damian Garde and BloombergJuly 11, 2024
Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
Commentary
Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
By Katie Britt, Terri Sewell, Kay Ivey and Randall WoodfinJuly 3, 2024
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
Commentary
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
By Anne E. WhiteJuly 2, 2024
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
Health
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
By Amanda LoudinJune 27, 2024
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream 
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream 
By Sharon GoldmanJune 25, 2024
1...
  • 12
  • 13
  • 14
  • 15
  • 16
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.